Table 2.
Main viro-immunological parameters of SSP and of VP according to the detection or not of HHV-8 shedding at T0 regardless of the presence or absence of EBV and/or CMV salivary shedding. Data are expressed as median and interquartile range (IQR). In bold significant P values
| SSP with HHV-8 shedding (n = 14) | VP with HHV-8 shedding (n = 15) | p | SSP with no HHV-8 shedding (n = 26) | VP with no HHV-8 shedding (n = 18) | p | |
|---|---|---|---|---|---|---|
| CD4 + cell count/mm3 | 590 (520–690) | 600(447–677) | 0.69 | 630(400–850) | 535(310–620) | 0.17 |
| CD4+ cell percentage | 26(24–36) | 23 (21–30) | 0.11 | 32 (22–36) | 22.5 (15–28) | 0.01 |
| CD8+ cell count/mm | 993 (522–1248) | 1106 (1014–1403) | 0.27 | 821 (619–1153) | 1106 (1010–1524) | 0.009 |
| CD8 + cell percentage | 44 (30–51) | 50 (47–53) | 0.09 | 43 (35–52) | 53.5 (48–60) | P < 0.001 |
| CD4+ cell count at nadir (cells/mm3) | 235 (140–340) | 440 (340–567) | 0.001 | 310(124–460) | 470 (300–530) | 0.09 |
T0: time of the first saliva sampling, after 24 months of plasma HIV RNA control analysis
SSPs HIV successfully suppressed patients, VPs HIV viremic patients